Unbuzzd Wellness Prepares for IPO with New Auditor and Name Change
TL;DR
Unbuzzd Wellness Inc. appoints MNP LLP for PCAOB audits in preparation for potential IPO, aligning with capital raising efforts.
Unbuzzd Wellness Inc. is conducting PCAOB audits with MNP LLP to prepare for IPO following financials resignation and name change.
Unbuzzd Wellness Inc.'s scientific beverage development and IPO preparation contribute to advancing health solutions for neurodegenerative and metabolic disorders.
Unbuzzd Wellness Inc.'s journey from scientific beverage creation to potential IPO showcases innovation and growth in the health and wellness industry.
Found this article helpful?
Share it with your network and spread the knowledge!
Unbuzzd Wellness Inc., a portfolio company of Quantum BioPharma, has taken significant steps toward a potential initial public offering (IPO) by appointing MNP LLP as its new auditing firm. The company, previously known as Celly Nutrition Corp., completed a formal name change on May 23, 2025, which will not impact existing shareholder rights or share certificates.
The auditor appointment follows the resignation of Stern & Lovrics LLP and aligns with the company's February 2025 announcement of engaging a New York investment bank for capital raising and public listing advisory services. This strategic move suggests Unbuzzd Wellness is preparing for increased financial scrutiny and potential market entry.
The appointment of MNP LLP, a Public Company Accounting Oversight Board (PCAOB) registered firm, indicates the company's commitment to rigorous financial reporting and transparency. By engaging a reputable auditing firm, Unbuzzd Wellness is positioning itself to meet the stringent financial disclosure requirements necessary for a successful public listing.
Quantum BioPharma, which retains a 25.71% ownership stake in Unbuzzd Wellness, stands to benefit from the potential IPO. The company will continue to receive royalty payments of 7% from Unbuzzd's sales until cumulative payments reach $250 million, after which the royalty will decrease to 3% in perpetuity.
These developments suggest Unbuzzd Wellness is making strategic preparations to enter the public market, potentially providing additional capital and visibility for its scientifically backed beverage product.
Curated from InvestorBrandNetwork (IBN)
